Actively Recruiting
Fertility-sparing Therapy for Patients With Stage IA Endometrial Cancer
Led by Peking University People's Hospital · Updated on 2023-07-14
57
Participants Needed
1
Research Sites
595 weeks
Total Duration
On this page
Sponsors
P
Peking University People's Hospital
Lead Sponsor
P
Peking University Third Hospital
Collaborating Sponsor
AI-Summary
What this Trial Is About
The goal of this clinical trial is to explore the feasibility and outcome of fertility-sparing therapy in Stage IA G1-G2 Endometrial Cancer with less than 1/2 myometrial invasion. Researchers will render participants indication-extended fertility-sparing therapy. Researchers will compare the myometrial invasion group with the no myometrial invasion group to see if it is possible to propose an extension indication of fertility-sparing therapy for endometrial cancer.
CONDITIONS
Official Title
Fertility-sparing Therapy for Patients With Stage IA Endometrial Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Stage IA (FIGO 2009)
- Pathological diagnosis of endometrial adenocarcinoma grade 1 or 2
- Tumor limited to the endometrium or invading less than half of the myometrium by MRI or ultrasound
- Age between 18 and 45 years old
- Strong desire to preserve fertility
- Signed informed consent
You will not qualify if you...
- Having any other malignancy
- Contraindications to conservative treatment
- Contraindications to progestin use
- Contraindications to pregnancy or judged unfit for pregnancy or delivery by the researcher
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Peking University People's Hosoital
Beijing, Beijing Municipality, China, 100044
Actively Recruiting
Research Team
J
Jianliu Wang, Professor
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here